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Introduction
Hypogonadism induced by systemic illness is not un-
common.1,2 The pathogenesis of hypogonadism is not
well understood. Herein we report a rare case with
metastatic prostate cancer to the pericardium who
experienced hypogonadism during the complicated
treatment course.
Case Report
A 68-year-old male had progressive dyspnea and pro-
ductive cough for 1 week. Chest radiography revealed
cardiomegaly (Figure 1) and cardial echography showed
massive pericardial effusion. Cytology from pericardio-
centesis showed adenocarcinoma, and serum prostate-
specific antigen (PSA) was 244 ng/mL. Pericardial
effusion recurred in 1 week, and perforation of the duo-
denum developed. Preoperative hepatic dysfunction was
found: total bilirubin was 6.2 mg/dL (normal range,
0.1–1.2 mg/dL), direct bilirubin was 3.6 mg/dL (nor-
mal range, 0–0.2 mg/dL), aspartate aminotransferase
(AST) was 544 U/L (normal range, 8–38 U/L), ala-
nine aminotransferase (ALT) was 1,142 U/L (normal
range, 4–44 U/L), alkaline phosphatase (ALK-P) was
259 U/L (normal range, 50–190 U/L), and albumin
was 2.5 g/dL (normal range, 3.5–5.0 g/dL). Surveys
of hepatitis A, B and C were all negative. Follow-up
PSA was 97.55 ng/mL.
The patient underwent subtotal gastrectomy and
Billroth II gastrojejunostomy. Pathology revealed se-
vere gastric and duodenal ulcer with perforation. Post-
operative duodenal stump leakage developed, and
localized peritonitis caused delayed enteral feeding.
Parenteral nutrition was given and jaundice persisted.
Two weeks after the operation, total bilirubin rose to
29.1 mg/dL and direct bilirubin rose to 17.0 mg/
dL. AST was 31 U/L, ALT was 8 U/L, and ALK-P
was 307 U/L. Gamma-glutamyl transpeptidase was
70 U/L (normal range, 8–61 U/L).
Enteral feeding started after 4 weeks of starvation, at
which time the liver function tests were still abnormal.
Total bilirubin was 24.2 mg/dL, direct bilirubin was
11.9 mg/dL, AST was 259 U/L, ALT was 138 U/L,
ALK-P was 579 U/L, and γ-glutamyl transpeptidase
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was 339 U/L. Abdominal computed tomography did
not show any abscess, intra-abdominal tumor or dilated
biliary tracts except for small retroperitoneal lymph-
adenopathy and bone metastases to the spine and
sacroiliac joint. The heart shadow from chest radiogra-
phy was normal. The sizes of the testicles on physical
examination were both 2.2 cm. Transrectal ultrasound-
guided biopsy showed adenocarcinoma of the prostate
with a Gleason score of 3 + 4. Bone scan revealed mul-
tiple bone metastases to the sacroiliac joint, spine and
ribs. PSA declined to 3.82 ng/mL and 1.94 ng/mL
in the 8th and 12th postoperative weeks, respectively.
Hypogonadism was also detected, with testosterone
level of 0.79 ng/mL. The patient died due to hepa-
torenal syndrome in the 12th week after surgery. The
complete treatment paradigm is shown in Figure 2.
Discussion
This is the first case report describing the PSA decline
effect in a newly diagnosed advanced prostate cancer
patient through hypogonadism induced by hepatic
failure. Two key points determined the diagnosis and
treatment in this case. First, what was the cause of liver
failure? During diagnosis, computed tomography, radi-
ography and endoscopy had excluded the sources of
obstructive jaundice and other intra-abdominal infec-
tions or tumors. Therefore, cholestasis induced by any
entity was the major pathway to liver damage. Table 1
lists the common differential diagnoses of cholestasis.3
In this patient, biliary obstruction, biliary sludge and
acalculous cholecystitis were excluded after imaging
studies. Acute cholangitis less likely developed in this
condition owing to lack of underlying liver disease
history. Viral hepatitis was excluded after blood tests,
and autoimmune hepatitis was not likely due to the
rapidly erupting disease process.4 Malignancy-induced
cholestasis has been reported in advanced prostate
cancer as a paraneoplastic syndrome.5 In our case, the
decline in serum PSA level did not correlate with
J Chin Med Assoc • July 2010 • Vol 73 • No 7390
C.C. Li, et al
Figure 1. Preoperative chest radiography shows cardiomegaly and
pericardial effusion.
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Figure 2. Summary of the patient’s hospitalization course.
Table 1. Differential diagnoses of cholestasis
1. Biliary obstruction
2. Biliary sludge
3. Acalculous cholecystitis
4. Acute bacterial cholangitis
5. Unrecognized liver disease
6. Malignancy (e.g. lymphoma)
7. Drug-induced cholestasis
8. Total parenteral nutrition
9. Sepsis
improvement of liver function. This clinical manifesta-
tion differs from that shown in a paraneoplastic syn-
drome. Based on the history of postoperative leakage
of the duodenal stump, subsequently localized peritoni-
tis and prolonged ileus, we regarded the liver failure as
a combined result of sepsis and medical treatment.
The mechanism of cholestasis induced by sepsis is
considered to be mediated systemically by proinflam-
matory cytokines.3 These cytokines, such as tumor
necrosis factor-α, interleukin (IL)-1 and IL-6, are re-
leased in response to the systemic inflammatory process
induced by lipopolysaccharides. Total parenteral nutri-
tion and some medications have been reported to be
hepatotoxic.6,7
Reviewing the medication used in this patient, total
parenteral nutrition with hepatic modification was pre-
scribed, antibiotics such as amoxicillin-clavulanic acid
were avoided, and other medications such as non-
steroidal anti-inflammatory drugs, opioids, antihyper-
tensives and antidiabetic agents were not consistently
used.7,8 Table 2 lists the systemic medications used in
the patient. However, with cautious treatment, hepatic
failure eventually developed due to irreversible dam-
age. The second key point: how did hypogonadism
develop during treatment? The mechanism of hypo-
gonadism in cirrhotic patients has been attributed to
malnutrition, and increasing estrogen conversion from
androgens.9 Vicentini et al observed low serum testos-
terone and PSA levels among cirrhotic patients, which
corresponded to this theory.2 Furthermore, hepatic
dysfunction reduces the synthesis of insulin-like growth
factor-1 in the liver and subsequently decreases testos-
terone synthesis. Another mechanism causing hypo-
gonadism is sepsis-induced organ injuries. Yang et al
described testis injuries in a sepsis rat model from
observing an increased concentration of nitric oxide-
derived nitrate anion in tissues.10 Nitrate anion can
facilitate vasopressin secretion and subsequently induce
vascular contraction and tissue hypoperfusion. More-
over, medications such as norepinephrine and octre-
otide used to maintain blood pressure and control
duodenal stump leakage may have compromised the
peripheral circulation and also impaired the testes func-
tion in this patient. These considerations corresponded
to the smaller testicles of the patient. In summary, the
possible mechanisms leading to hypogonadism in this
patient are presented in Figure 3.
The treatment of this patient was mainly focused
on the prevention of hepatotoxicity and the restoration
of enteral nutrition. Serum PSA declined gradually
without any treatment. In summary, we have reported
a rare case of malignant pericardial effusion due to
metastatic prostate cancer. Hepatic failure developed
during treatment and induced hypogonadism and
spontaneous decline of serum PSA level.
References
1. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW,
Bartfai G, et al. Hypothalamic-pituitary-testicular axis disruptions
in older men are differentially linked to age and modifiable risk
factors: the European Male Aging Study. J Clin Endocrinol
Metab 2008;93:2737–45.
2. Vicentini FC, Botelho LA, Hisano M, Ebaid GX, Lucon M,
Lucon AM, Srougi M. Are total prostate-specific antigen serum
J Chin Med Assoc • July 2010 • Vol 73 • No 7 391
Hepatic failure in a non-treated prostate cancer patient
Hypothalamus–pituitary
Liver
(dysfunction)
Growth hormone
+
+
IGF-1(↓)
−
−
−
−
Sepsis
Malnutrition
Medication
(vasopressor)
Testes (↓)
Androgen
conversion
to estrogen
in peripheral
tissue
Figure 3. Illustration of endocrine control axis leading to hypogo-
nadism. In hepatic dysfunction, the sensitivity of growth hormone
receptors decrease and reduce the synthesis of insulin-like
growth factor-1 (IGF-1). Subsequently, the stimulation of the
testes decreases. Hepatic dysfunction increases the conversion
of androgen to estrogen in peripheral tissue. Malnutrition, sepsis
and medication compromises testicular function through
decrease of nutrition and perfusion.
Table 2. Possible hepatotoxic or hypogonadism medications
used in the patient
Antibiotics
Fluconazole
Nonsteroidal anti-inflammatory drugs
Ketorolac
Diclofenac
Hypnotics
Midazolam
Miscellaneous
Octreotide
Norepinephrine
Total parenteral nutrition
levels in cirrhotic men different from those in normal men?
Urology 2009;73:1032–5.
3. Gilroy RK, Mailliard ME, Gollan JL. Gastrointestinal disorders
of the critically ill: cholestasis of sepsis. Best Pract Res Clin
Gastroenterol 2003;17:357–67.
4. Tang CP, Shiau YT, Huang YH, Tsay SH, Huo TI, Wu JC, 
Lin HC, et al. Cholestatic jaundice as the predominant presen-
tation in a patient with autoimmune hepatitis. J Chin Med
Assoc 2008;71:45–8.
5. Karakolios A, Kasapis C, Kallinikidis T, Kalpidis P, Grigoriadis N.
Cholestatic jaundice as a paraneoplastic manifestation of
prostate adenocarcinoma. Clin Gastroenterol Hepatol 2003;1:
480–3.
6. Guglielmi FW, Regano N, Mazzuoli S, Fregnan S, Leogrande
G, Guglielmi A, Merli M, et al. Cholestasis induced by total
parenteral nutrition. Clin Liver Dis 2008;12:97–110.
7. Chitturi S, George J. Hepatotoxicity of commonly used drugs:
nonsteroidal anti-inflammatory drugs, antihypertensives, anti-
diabetic agents, anticonvulsants, lipid-lowering agents, psycho-
tropic drugs. Semin Liver Dis 2002;22:169–83.
8. Gresser U. Amoxicillin-clavulanic acid therapy may be associated
with severe side effects: review of the literature. Eur J Med Res
2001;6:139–49.
9. Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE,
Diez-Caballero F, Quiroga J, Diaz-Sanchez M, et al. Hemato-
testicular barrier is altered from early stages of liver cirrhosis:
effect of insulin-like growth factor 1. World J Gastroenterol
2004;10:2529–34.
10. Yang F, Comtois AS, Fang L, Hartman NG, Blaise G. Nitric
oxide-derived nitrate anion contributes to endotoxic shock and
multiple organ injury/dysfunction. Crit Care Med 2002;30:
650–7.
J Chin Med Assoc • July 2010 • Vol 73 • No 7392
C.C. Li, et al
